Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peijun Tang

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Infection and Drug Resistance|September 2, 2024
Treatment Outcomes and Associated Influencing Factors Among Patients with Rifampicin-Resistant Tuberculosis: A Multicenter, Retrospective, Cohort Study in ChinaLiping Zou, Wanli Kang, Chunhui Guo, et al.
Scientific Reports|November 5, 2025
Prevalence of comorbidities and their impact on prognosis among patients with rifampicin-resistant tuberculosis: a multicenter retrospective cohort study in ChinaLiping Zou, Zhili Li, Qing Pan, et al.
Emerging Microbes & Infections|November 15, 2022
Accuracy of Xpert® MTB/RIF Ultra test for posterior oropharyngeal saliva for the diagnosis of paucibacillary pulmonary tuberculosis: a prospective multicenter studyPeijun Tang, Rongmei Liu, Lin Qin, et al.
Journal of Immunology Research|March 28, 2022
Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant TuberculosisPeijun Tang, Xingnian Chen, Junchi Xu, et al.
Journal of Thoracic Disease|October 29, 2025
Use of metagenomic next-generation sequencing for accurate diagnosis of tuberculous pleurisy: a retrospective cohort studyJing Liu, Huiwen Qian, Jianqiang Jin, et al.
BMC Infectious Diseases|September 1, 2025
Treatment outcomes and associated influencing factors among elderly patients with rifampicin-resistant tuberculosis: a multicenter, retrospective, cohort study in ChinaHuicong Liu, Liping Zou, JiaJia Yu, et al.
Nature Communications|January 3, 2024
Terminal modifications independent cell-free RNA sequencing enables sensitive early cancer detection and classificationJun Wang, Jinyong Huang, Yunlong Hu, et al.
The European Respiratory Journal|December 23, 2018
Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort studyFeng Sun, Yang Li, Yu Chen, et al.
Cancer Cell|September 1, 2015
IL-36γ Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune ResponsesXuefeng Wang, Xin Zhao, Chao Feng, et al.
Infectious Diseases and Therapy|January 30, 2021
Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort StudyLi Shi, Jingtao Gao, Mengqiu Gao, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Infection and Drug Resistance|September 2, 2024
Treatment Outcomes and Associated Influencing Factors Among Patients with Rifampicin-Resistant Tuberculosis: A Multicenter, Retrospective, Cohort Study in ChinaLiping Zou, Wanli Kang, Chunhui Guo, et al.
Scientific Reports|November 5, 2025
Prevalence of comorbidities and their impact on prognosis among patients with rifampicin-resistant tuberculosis: a multicenter retrospective cohort study in ChinaLiping Zou, Zhili Li, Qing Pan, et al.
Emerging Microbes & Infections|November 15, 2022
Accuracy of Xpert® MTB/RIF Ultra test for posterior oropharyngeal saliva for the diagnosis of paucibacillary pulmonary tuberculosis: a prospective multicenter studyPeijun Tang, Rongmei Liu, Lin Qin, et al.
Journal of Immunology Research|March 28, 2022
Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant TuberculosisPeijun Tang, Xingnian Chen, Junchi Xu, et al.
Journal of Thoracic Disease|October 29, 2025
Use of metagenomic next-generation sequencing for accurate diagnosis of tuberculous pleurisy: a retrospective cohort studyJing Liu, Huiwen Qian, Jianqiang Jin, et al.
BMC Infectious Diseases|September 1, 2025
Treatment outcomes and associated influencing factors among elderly patients with rifampicin-resistant tuberculosis: a multicenter, retrospective, cohort study in ChinaHuicong Liu, Liping Zou, JiaJia Yu, et al.
Nature Communications|January 3, 2024
Terminal modifications independent cell-free RNA sequencing enables sensitive early cancer detection and classificationJun Wang, Jinyong Huang, Yunlong Hu, et al.
The European Respiratory Journal|December 23, 2018
Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort studyFeng Sun, Yang Li, Yu Chen, et al.
Cancer Cell|September 1, 2015
IL-36γ Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune ResponsesXuefeng Wang, Xin Zhao, Chao Feng, et al.
Infectious Diseases and Therapy|January 30, 2021
Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort StudyLi Shi, Jingtao Gao, Mengqiu Gao, et al.
Pageof 8